ArticleFrontiers in immunology2026

Case Report: Immune-directed post-transplant maintenance with low-dose gemtuzumab ozogamicin and stepwise donor lymphocyte infusion in acute myeloid leukemia with t(1;3)(p36.3;q21).

Fumihiko Ouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.